Our knowledge display that CK18 is consistently expressed in numerous epithelial cancers, In particular adenocarcinomas. the two lack of CK18 expression in cancers derived from CK18 beneficial precursor cells and neo-expression in malignancies derived from CK18 beneficial precursors are generally linked to unfavorable tumor phenotype and disease re